ADI-PEG20
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ADI-PEG20, covering 2024-11-07 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) [Phase 1, Phase 2]